Loading...
Understanding ADHD in the UK
Your brain worksdifferently
Evidence-based information about ADHD, designed for adults in the UK.
2-3%UK adults with ADHD
1M+People in the UK
The Basics
What is ADHD?
Wired Differently
ADHD brains have different levels of dopamine and norepinephrine, affecting motivation, focus, and reward.
Common in the UK
Around 2 to 3% of UK adults have ADHD. That's over 1 million people, many still undiagnosed.
Not Just Childhood
ADHD doesn't disappear at 18. For most people, symptoms continue throughout life, evolving with age.
The Neuroscience
How the ADHD Brain Works
Research has identified four key brain regions that function differently in ADHD. Understanding these differences helps explain why certain tasks feel challenging—and why others feel effortless.
Front of brain
Frontal Cortex
The command centre for attention, planning, and organisation
In ADHD
Lower activity leads to difficulty with executive functions—starting tasks, organising thoughts, and maintaining focus on less stimulating activities. Research shows the prefrontal cortex matures later in ADHD, with developmental delays most prominent in regions controlling working memory and impulse inhibition.
Brain Chemistry
The Chemical Messengers
Two key neurotransmitters play a major role in ADHD. Understanding them helps explain both the challenges and the treatments.
Dopamine
The Motivation Molecule
Dopamine drives reward, pleasure, and motivation. In ADHD, lower dopamine in key brain regions makes it harder to feel motivated by future rewards—explaining why immediate deadlines work better than distant ones.
Norepinephrine
The Focus Fuel
Norepinephrine helps with alertness, focus, and attention. It's essential for the prefrontal cortex to function properly. Too little leads to difficulty concentrating; too much can cause anxiety.
UK Treatment Options
ADHD Medications in the UK
Medication can be an effective part of ADHD treatment. In the UK, all ADHD medications require a specialist diagnosis and ongoing monitoring by a qualified prescriber.
Stimulant (first-line for most)
Methylphenidate
Increases dopamine and norepinephrine in the brain
Most commonly prescribed ADHD medication in the UK
Other medications in this category:
Getting Medication in the UK
- Requires diagnosis from a specialist clinician (psychiatrist or qualified prescriber)
- Annual reviews required to continue treatment
- Stimulants are Schedule 2 controlled drugs—prescriptions are limited to 30 days
- Physical monitoring (blood pressure, pulse, weight) required every 6 months
- Different brands of methylphenidate are not interchangeable—always take the prescribed brand
Daily Life
Living with ADHD
ADHD affects daily life in ways that aren't always obvious. Understanding these impacts can help you develop strategies that work with your brain, not against it.
Many adults with ADHD thrive in careers that offer variety, creativity, and urgency. Challenges often include administrative tasks, long meetings, and maintaining focus on routine work. Strengths commonly include problem-solving, creativity, and handling crises. Many find success in entrepreneurial roles, creative fields, emergency services, and positions that value out-of-the-box thinking.
"
Understanding my ADHD helped me stop fighting myself and start working with my brain.
✦
Community MemberA Journey of Understanding
The History of ADHD
Swipe to explore how our understanding has evolved over two centuries
Beginning
01
1798
First Medical Description
Scottish physician Sir Alexander Crichton describes 'abnormal inattention' as a condition present from birth, noting symptoms tend to lessen with age.
Milestone
02
1902
Still's Lectures
British paediatrician Sir George Frederic Still describes children with 'defect of moral control'—intelligent children who struggle with attention and self-regulation. He notes it's likely hereditary, not environmental.
Milestone
03
1937
Accidental Discovery
Dr. Charles Bradley discovers that stimulant medication (Benzedrine) improves behaviour and school performance in children with behavioural problems—though his findings are largely ignored for decades.
Milestone
04
1954
Ritalin Arrives
Methylphenidate (Ritalin) is first marketed. Originally developed in 1944, it becomes increasingly used for ADHD as understanding grows.
Milestone
05
1968
DSM-II Recognition
The American Psychiatric Association's DSM-II includes 'Hyperkinetic Reaction of Childhood'—the first official diagnostic category.
Milestone
06
1980
ADD is Named
DSM-III introduces "Attention Deficit Disorder" with two subtypes: with and without hyperactivity. For the first time, inattentive presentation is recognized.
Milestone
07
1987
ADHD as We Know It
DSM-III-R renames the condition "Attention Deficit Hyperactivity Disorder," combining inattentiveness, impulsivity, and hyperactivity.
Milestone
08
1994
Three Subtypes
DSM-IV defines three ADHD subtypes: Predominantly Inattentive, Predominantly Hyperactive-Impulsive, and Combined.
Milestone
09
2013
Adult ADHD Recognized
DSM-5 acknowledges that ADHD persists into adulthood and can be diagnosed in adults, even without childhood documentation.
Present
10
2024
UK Taskforce Report
The independent NHS ADHD Taskforce publishes comprehensive recommendations to improve ADHD services in England, highlighting significant unmet need.
Get Support
UK ADHD Resources
Support is available. These organisations provide information, community, and guidance for adults with ADHD in the UK.
Need Immediate Support?
If you're struggling with your mental health, help is available 24/7.
If you decide a private assessment is the right next step for you, you can start from home with Dopa.
Start your ADHD assessment